The effect of Helicobacter pylori eradication in patients with functional dyspepsia: Assessment of different diagnostic tests

Turkish Journal of Gastroenterology

Volumn 15, Issue 3, 2004, Pages 159-163

  Çinar, Kubilay ^a   Soykan, Irfan ^a   Özden, Ali ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Bismuth; Eradication; Functional dyspepsia; Helicobacter pylori

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; RANITIDINE BISMUTH CITRATE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIGEN DETECTION; ARTICLE; BACTERIUM DETECTION; BREATHING; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DYSPEPSIA; ERADICATION THERAPY; FECES ANALYSIS; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANTACIDS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; ANTIGENS; BIOPSY; BREATH TESTS; CLARITHROMYCIN; COLONY COUNT, MICROBIAL; CYTOLOGICAL TECHNIQUES; DYSPEPSIA; ENDOSCOPY, GASTROINTESTINAL; FECES; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; RANITIDINE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 33144477951     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Schlemper RJ, van der Werf SD, Biemond I, Lamers CB. Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease. Eur J Gastroenterol Hepatol 1996; 8: 33-9.
2. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review Gastroenterology. 1996; 110: 1244-52.
3. Morgner A, Lehn N, Andersen LP, et al. Helicobacter heilmanniiassociated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. Gastroenterology 2000; 118: 821-8.
4. Dixon MF. Pathology of gastritis and peptic ulceration. In: Mobley HLT, Mendz GL, Hazell SL, eds. Helicobacter pylori: physiology and genetics. Washington, D. C. : ASM Press, 2001: 459-69.
5. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267-71.
6. Wotherspoon AC. Helicobacter pylori infection and gastric lymphoma. Br Med Bull 1998; 54: 79-85.
7. Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995; 345: 1591-4.
8. Malaty HM, Graham DY. Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut 1994; 35: 742-5.
9. Us D, Hascelik G. Seroprevalence of Helicobacter pylori infection in an Asymptomatic Turkish population. J Infect. 1998 Sep; 37(2): 148-50.
10. McColl K, Murray L, El-Omar E, et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998; 339: 1869-74.
11. Moayyedi P, Soo S, Deeks J, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2001; 1: CD002096.
12. Soll AH. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. JAMA 1996 Feb28 ; 275(8): 622-9.
13. Walsh JH, Peterson WL The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995 Oct 12; 333(15): 984-91.
14. Howden CW, Hunt RH. Guidelines for the management of Helicobacter pylori infection. Am J Gastroenterol 1998; 93: 2330-8.
15. Drumm B, Koletzko S, Oderda G. Helicobacter pylori infection in children: a consensus statement. J Pediatr Gastroenterol Nutr 2000; 30: 207-13.
16. Graham DY, Qureshi WA. Markers of infection. In: Mobley HLT,Mendz GL, Hazell SL, eds. Helicobacter pylori: physiology and genetics. Washington, D. C. : ASM Press, 2001: 499-510.
17. Gene E, Calvet X, Azagra R, Gisbert JP. Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis. Aliment Pharmacol Ther. 2003: May: 1; 17(9): 1137-43.
18. 20th National Gastroenterology Week Abstracts Kusadasi/Turkey. The Turkish J. Gastroenterology Sept 2003; 14 Suppl. 1.
19. Peterson WL, Ciociola AA, Sykes DL, McSorley DJ, Webb DD. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. Aliment Pharmacol Ther 1996; 10: 251-61.
20. Gisbert JP, Gonzalez L, Calvet X, Roque M, Gabriel R, Pajares JM. Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy. Aliment Pharmacol Ther 2000; 14: 1141-50.
21. Sung JJ, Chan FK, Wu JC, et al. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study. Aliment Pharmacol Ther 1999; 13: 1079-84.
22. Hojo M, Miwa H, Nagahara A, Sato N. Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection. Scand J Gastroenterol 2001; 36: 690-700.
23. Perri F, Villani MR, Quitadamo M, Annese V, Niro GA, Andriulli A. Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy? Aliment Pharmacol Ther 2001; 15: 1017-22.
24. Bazzoli F. Key points from the revised Maastricht Consensus Report: the impact on general practice. Eur J Gastroenterol Hepatol 2001; 13: Suppl 2: S3-S7.
25. Talley NJ. Update on the role of drug therapy in non-ulcer dyspepsia. Rev Gastroenterol. Disord. 2003: Winter; 3(1): 25-30.
26. Alizadeh-Naeeni M, Saberi-Firoozi M, Pourkhajeh A, Talleri H, Malekzadeh R, Derakhshan MH, Massarrat S; Iranian Functional Dyspepsia Study Group. Effect of Helicobacter pylori eradication or of ranitidine plus metoclopramide on Helicobacter pylori-positive functional dyspepsia. A randomized, controlled follow-up study. Digestion. 2002; 66(2): 92-8.
27. Saruc M, Ozden N, Turkel N, Ayhan S, Demir MA, Tuzcuoglu I, Akarca US, Yuceyar H. Functional dyspepsia: relationship between clinical subgroups and Helicobacter pylori status in Western Turkey. Braz J Med Biol Res. 2003 Jun; 36(6): 747-51.